Dec 10, 2024, 13:56
Eddie Cliff: Headline results of updated TRIANGLE study
Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, posted the following on X:
“ASCT is dead! Long live ASCT!
Headline results of updated TRIANGLE study results from Martin Dreyling EMCL network.
Overall survival benefit ~10% for both ibrutinib-containing arms over ASCT alone.
Little benefit to ASCT.
Practice-changing result.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 10, 2024, 13:56
Dec 10, 2024, 13:56
Dec 10, 2024, 13:53
Dec 10, 2024, 13:50
Dec 10, 2024, 13:49
Dec 10, 2024, 13:25
Dec 10, 2024, 12:47
Dec 10, 2024, 12:41
Dec 10, 2024, 12:21
Dec 10, 2024, 11:19